Robert Dreicer, MD
Enriched profileDeputy Director, UVA Comprehensive Cancer Center; Associate Director for Clinical Research; Head, Section of Medical Oncology; Co-Director, Paul Mellon Urologic Institute; Professor of Medicine and Urology, University of Virginia School of Medicine · University of Virginia School of Medicine
Robert Dreicer is Deputy Director, UVA Comprehensive Cancer Center; Associate Director for Clinical Research; Head, Section of Medical Oncology; Co-Director, Paul Mellon Urologic Institute; Professor of Medicine and Urology, University of Virginia School of Medicine at University of Virginia School of Medicine. OpenAlex indexes 838 publications with 38,325 citations (h-index 76); ClinicalTrials.gov lists 10 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Medical Oncology profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 14 Oct 2026
Robert Dreicer, M.D., is Deputy Director, UVA Comprehensive Cancer Center at University of Virginia School of Medicine / UVA Comprehensive Cancer Center. The public record shows 838 publications with 38,325 citations (h-index 76), centered on Prostate Cancer Treatment and Research, Prostate Cancer Diagnosis and Treatment, Bladder and Urothelial Cancer Treatments. It also documents an investigator role on 10 registered clinical trials, industry payments reported by 17 companies, 1 NIH-funded awards (2020–2021).
- Top research focus: Prostate Cancer Treatment and Research
- 10 registered trials on ClinicalTrials.gov
- Open Payments reporting from 17 companies
Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 6 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 235.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 14 Oct 2026
Listed as an investigator on 10 registered studies on ClinicalTrials.gov. The most recent:
- Lenalidomide and GM-CSF in Treating Patients With Prostate Cancer
Sponsor: Robert Dreicer MD
- GM-CSF in Treating Patients With Relapsed Prostate Cancer
Sponsor: Case Comprehensive Cancer Center
- CC-4047 in Treating Patients With Advanced Solid Tumors That Did Not Respond to Treatment
Sponsor: Case Comprehensive Cancer Center
Industry payments
Updated 14 Oct 2026
17 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Merck Sharp & Dohme LLCProgram year202514 payments$19,195openpaymentsdata.cms.gov ↗
- UROGEN PHARMA, INC.Program year20257 payments
- PFIZER INC.Program year20256 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
57.5%Cytochrome P450 17A1 Inhibitor57.5%Abiraterone Acetate100%Part D<11 patientsMetabolism & gastrointestinal
42.5%Corticosteroid42.5%Prednisone100%Part D≥17 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 14 Oct 2026
1 NIH research award on record, funded 2020–2021 per NIH RePORTER. The latest:
- CWRU Case Comprehensive Cancer Center NCTN Lead Academic Participating Site
Case Western Reserve University
FY2015$171,796U10CA180853
Congress activity
Updated 14 Oct 2026
156 congress contributions (2003–2026) across AACR, ASCO, ASTRO, ESMO per OpenAlex. The most recent:
- Initial findings from the PROMISE Registry, a US decentralized, prospective prostate cancer genetic registry.
ASCO Annual Meeting
ASCO2026Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Most-cited works
by citation count (OpenAlex)- 01Sipuleucel-T Immunotherapy for Castration-Resistant Prostate CancerArticle5,521 citations2010
- 02
- 03Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate CancerArticle2,863 citations2015
- 04
- 05
Network
Updated 14 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 14 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/robert-dreicer-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/dreicer-robert-b332b7aa
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - ResearchGate
researchgate.net/profile/Robert-Dreicer
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
Mentions by others
where others cite or feature them- Facebook
facebook.com/uvacancerctr/videos/meet-uva-hematologist-oncologist-dr-robert-dreicer/505934847001183
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facebook.com ↗ - Facebook
facebook.com/uvahealth/posts/hematologistoncologist-robert-dreicer-md-is-deputy-director-of-uva-cancer-center/1098305166883928
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facebook.com ↗ - Instagram
instagram.com/reel/C4RO9Adgcrp
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →instagram.com ↗ - Other
player.fm/series/peerview-oncology-hematology-cmecnecpe-audio-podcast/robert-dreicer-md-ms-macp-fascopedro-c-barata-md-msc-personalizing-and-advancing-modern-treatment-approaches-to-prostate-cancer
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →player.fm ↗ - Other
society.asco.org/people/robert-dreicer-md-ms-facp-fasco
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →society.asco.org ↗ - Other
onclive.com/authors/robert-dreicer-md
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →onclive.com ↗ - Other
urotoday.com/video-lectures/advanced-bladder-cancer/video/2623-navigating-the-complex-landscape-of-adjuvant-trials-in-urothelial-carcinoma-robert-dreicer.html
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →urotoday.com ↗ - YouTube
youtube.com/watch
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗ - YouTube
youtube.com/watch
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 14 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- M.D.
University of Texas Medical School at Houston
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.virginia.edu ↗ - M.S.
University of Texas Graduate School of Biomedical Sciences at Houston
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bcan.org ↗ - B.S.
Colorado State University
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →bcan.org ↗ - Internal Medicine Residency
Indiana University Medical Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.virginia.edu ↗ - Clinical Fellowship
Hematology-Oncology, University of Wisconsin (Carbone Cancer Center)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.virginia.edu ↗
Editorial & leadership roles
journal and society appointments- Associate Editor
NEJM Clinician (formerly NEJM Journal Watch Hematology/Oncology)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.virginia.edu ↗ - Editorial board member
Current Urology Reports
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →clinician.nejm.org ↗ - Co-Chair
NCI Genitourinary Oncology Steering Committee (past)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.virginia.edu ↗ - Member
Medical Oncology Longitudinal Knowledge Assessment Committee, American Board of Internal Medicine (past)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.virginia.edu ↗
Awards & honors
honors on the public record- Master
American College of Physicians (MACP)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →targetedonc.com ↗ - Fellow
American Society of Clinical Oncology (FASCO)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bcan.org ↗
Media & interviews
press, podcasts and appearances- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →facebook.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →onclive.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →audible.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
William Petri, MD
University of Virginia School of Medicine
Antonio Abbate, MD
University of Virginia School of Medicine
Cirle Warren, MD
University of Virginia School of Medicine
Scott Heysell, MD, MPH
University of Virginia School of Medicine
Howard Scher, MD
Memorial Sloan Kettering Cancer Center
Toni Choueiri, MD
Dana-Farber Cancer Institute
Robert Motzer, MD
Memorial Sloan Kettering Cancer Center
Fred Saad, MD
Centre hospitalier de l'Université de Montréal (CHUM)